SB 726 - Hoskins, Denny
Removes the expiration date on certain provisions relating to gender transition
Bill Details
Sponsor
LR Number
3681S.01I
Title
SB 726
House Handler
N/A
Journal Page
Effective Date
August 28, 2024
Committee
Current Status
Second Read and Referred S Emerging Issues Committee
Quick Links
Amendments
No amendments available
CURRENT BILL SUMMARY
SB 726 - Currently, the prohibition on the prescription or administration of cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for persons under 18 years of age expires on August 28, 2027. This act removes that expiration date.
This act is identical to SB 776 (2024) and SB 1185 (2024) and similar to provisions in HCS/HBs 1520, 1519, 2355, and 2357 (2024).
SARAH HASKINS